<p>In this episode, we examine a pair of early-stage drug development stocks at the forefront of cancer research: Theralase Technologies (TSXV:TLT) and Oncolytics Biotech (NASDAQ:ONCY).</p>

In this episode, we examine a pair of early-stage drug development stocks at the forefront of cancer research: Theralase Technologies (TSXV:TLT) and Oncolytics Biotech (NASDAQ:ONCY).

Ep. 37: Pharma stocks in the fight against cancer

<p>Tired of hour-long financial shows? Welcome to The 5 Minute Investor, the podcast that gets straight to the point. Every episode, join Stockhouse columnists Jonathon Brown and Trevor Abes as they deliver two quick, actionable stock picks in just five minutes. We cut through the noise to bring you compelling investment ideas in today's hottest sectors, including AI, tech, lithium, mining, and more. Whether you're a seasoned pro or just starting out, get your daily dose of market analysis and discover your next potential investment. This is not financial advice.</p>

Business

Entrepreneurship

News

Investing

Business News

Tired of hour-long financial shows? Welcome to The 5 Minute Investor, the podcast that gets straight to the point. Every episode, join Stockhouse columnists Jonathon Brown and Trevor Abes as they deliver two quick, actionable stock picks in just five minutes. We cut through the noise to bring you compelling investment ideas in today's hottest sectors, including AI, tech, lithium, mining, and more. Whether you're a seasoned pro or just starting out, get your daily dose of market analysis and discover your next potential investment. This is not financial advice.

Share Ep. 37: Pharma stocks in the fight against cancer

Sign up to save your podcasts

Ep. 37: Pharma stocks in the fight against cancer

Ep. 37: Pharma stocks in the fight against cancer

More shows like The 5 Minute Investor Podcast

The Joe Rogan Experience

Wall Street Breakfast

The Dividend Guy Blog Podcast

The Rational Reminder Podcast